MURALIDHAR KRISHNAIAH: Open Payments
NPI 1427071729 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 35 payments from 8 companies in 2025. Trend: 2023 $450 · 2024 $525 · 2025 $748
Food & beverage: $637Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $289 |
| Janssen Pharmaceuticals, Inc | 7 | $141 |
| Alkermes, Inc. | 4 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Neurocrine BioSciences, Inc. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
Products named: UZEDY, INVEGA SUSTENNA, CAPLYTA, INGREZZA, COBENFY, SPRAVATO, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across NJ — which companies pay providers there.
